PVLA

PALVELLA THERAPEUTICS INC NE

PVLA·697947109·US·Common Stock·Healthcare - Biotechnology-13D/G

PVLA (PALVELLA THERAPEUTICS INC NE) is held by 105 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($85.6M), JENNISON ASSOCIATES LLC ($79.9M), VANGUARD CAPITAL MANAGEMENT LLC ($59.5M). Net institutional sentiment: Bullish.

105
Holders
Avg rating(24 Elite)
$881.3M
Total Value
75% (111)
Fund Consensus
79 buying - 26 selling
PVLASmart Money Verdict
View all
Held by 105 funds
24 elite
Who's Trading
InsiderGKGoin KathleenSell $189KApr 15, 2026
InsiderGKGoin KathleenSell $191KApr 15, 2026
InsiderGKGoin KathleenSell $72KApr 15, 2026
InsiderGKGoin KathleenSell $83KApr 15, 2026
InsiderGKGoin KathleenSell $13KApr 15, 2026
InsiderJMJENKINS GEORGE MBuy $50KMar 30, 2026
InsiderGKGoin KathleenSell $267KMar 18, 2026
InsiderGKGoin KathleenSell $205KMar 18, 2026
ActivistBVBIOTECHNOLOGY VALUE FUND L P3.8%Feb 17, 2026
ActivistFLFirst Light Asset Management, LLC7.5%Feb 17, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
686,853(+22.9%)$85.6M0.0%+169.63%
36
Increased
640,611(+65.3%)$79.9M0.1%+36.44%
44
New
477,294$59.5M0.0%+10.08%
41
Increased
458,999(+9.2%)$57.2M0.0%+71.79%
32
Increased
433,015(+17.6%)$54M0.1%+92.60%
34
Increased
402,564(+9742.6%)$50.2M0.0%+10.63%
47
New
374,035$46.6M0.5%+10.08%
48
Increased
317,517(+5.7%)$39.6M0.1%+375.95%
37
Decreased
262,835(-2.3%)$27.5M0.0%+44.93%
0
Decreased
215,808(-6.9%)$26.9M0.0%+76.69%
0
Increased
205,609(+14.9%)$25.6M0.0%+245.08%
33
New
195,030$24.3M0.0%+10.08%
40
Increased
194,179(+96.3%)$24.2M0.0%+62.49%
46
Decreased
193,796(-8.4%)$24.2M0.0%+44.93%
0
New
179,922$22.4M0.1%+10.08%
39
Decreased
127,987(-42.0%)$16M0.0%+179.40%
0
Increased
104,537(+186.4%)$13M0.0%+37.20%
45
Decreased
96,726(-11.2%)$12.1M0.0%+132.55%
0
Increased
93,646(+2591.0%)$11.7M0.0%+13.42%
45
New
90,858$11.3M0.0%+10.08%
39

Showing 1-20 of 111

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used